NEW YORK (GenomeWeb) – Meridian Bioscience today reported its first quarter revenues rose 12 percent, with growth in both its life sciences and diagnostics businesses somewhat offset by losses in its Magellan lead testing unit.

For the three months ended Dec. 31, 2017, revenues increased to $52.3 million from $46.8 million a year ago, beating Wall Street analysts' average estimate of $49.0 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.